SI-BONE To Report First Quarter 2023 Financial Results on
SANTA CLARA, Calif., April 10, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal...
Source: globenewswire.com
📰 Si Bone News
Page 6 - Si Bone News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Si Bone. Real-time updates on events, politics, business and more.
SI-BONE, Inc. (NASDAQ:SIBN) Insider Anthony J. Recupero Sells 1,712 Shares
SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) insider Anthony J. Recupero sold 1,712 shares of the business’s stock in a transaction that occurred on Monday, April 3rd. The stock was sold at an average price of $19.28, for a total value of $33,007.36. Following the completion of the sale, the insider now owns 227,815 shares of […]
Zurcher Kantonalbank Zurich Cantonalbank Anthonyj Recupero Cantor Fitzgerald Tower Research Capital Ensign Peak Advisors Inc Canaccord Genuity Group
Source: kopsource.com
SI-BONE, Inc. (NASDAQ:SIBN) CFO Anshul Maheshwari Sells 1,229 Shares of Stock
SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) CFO Anshul Maheshwari sold 1,229 shares of the company’s stock in a transaction dated Monday, April 3rd. The shares were sold at an average price of $19.30, for a total transaction of $23,719.70. Following the completion of the sale, the chief financial officer now directly owns 159,697 shares of […]
Anshul Maheshwari Zurcher Kantonalbank Zurich Cantonalbank Simplex Trading Canaccord Genuity Group Cantor Fitzgerald Needham Company
Source: themarketsdaily.com
SI-BONE, Inc. (NASDAQ:SIBN) Receives $24.63 Average Target Price from Analysts
SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) has been given a consensus rating of “Buy” by the eight brokerages that are presently covering the firm, MarketBeat reports. Seven investment analysts have rated the stock with a buy recommendation. The average 1 year price target among analysts that have updated their coverage on the stock in the […]
Jeffreyw Dunn Laura Francis Cantor Fitzgerald Voya Investment Management Equity Group Morgan Stanley
Source: theenterpriseleader.com
SI-BONE, Inc. (NASDAQ:SIBN) Receives Consensus Rating of "Buy" from Analysts
SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) has been assigned an average recommendation of “Buy” from the eight analysts that are presently covering the firm, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 12-month price target among analysts that have issued ratings on the stock in the last year […]
Anshul Maheshwari Michaela Pisetsky Morgan Stanley Company Profile Metlife Investment Management Needham Company
Source: wkrb13.com
SI-BONE To Report Fourth Quarter 2022 Financial Results on
SANTA CLARA, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal...
Source: globenewswire.com
SI-BONE, Inc. Announces FDA Clearance for Expanded
Use Includes Pelvic Fragility Fractures...
Michael Gardner Orthopedic Trauma At Stanford University Hospital Globe Newswire Inc Silicon Valley Based Orthopedic Trauma Stanford University
Source: globenewswire.com
Zacks: Brokerages Expect SI-BONE, Inc. (NASDAQ:SIBN) Will Post Quarterly Sales of $25.11 Million
Brokerages predict that SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) will report sales of $25.11 million for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for SI-BONE’s earnings, with the lowest sales estimate coming in at $24.42 million and the highest estimate coming in at $25.79 million. SI-BONE reported sales of […]
United States Anthonyj Recupero Jeffreyw Dunn Morgan Stanley Geode Capital Management Zacks Investment Research
Source: etfdailynews.com
SI-BONE (NASDAQ:SIBN) Receives Buy Rating from JMP Securities
SI-BONE (NASDAQ:SIBN – Get Rating)‘s stock had its “buy” rating restated by stock analysts at JMP Securities in a research report issued on Wednesday, TipRanks reports. They presently have a $36.00 price target on the stock. JMP Securities’ price objective suggests a potential upside of 149.13% from the company’s previous close. SIBN has been the […]
United States Michaela Pisetsky Jeffreyw Dunn Morgan Stanley Zacks Investment Research Maverick Capital Ltd
Source: etfdailynews.com
SI-BONE, Inc. Receives FDA 510(k) Clearance for iFuse
SANTA CLARA, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving...
Joe Powers Matt Bacso Laura Francis Christopher Shaffrey Scott Alexander Innovation At Mercy Health System
Source: globenewswire.com